Assessment of myocardial postreperfusion viability by intravenous myocardial contrast echocardiography analysis of the intensity and texture of opacification

Circulation

Volumn 103, Issue 15, 2001, Pages 2021-2027

  Ohmori, Koji ^a,b   Cotter, Bruno ^a   Leistad, Elisabeth ^a   Bhargava, Valmik ^a   Wolf, Paul L ^a   Mizushige, Katsufumi ^a,b   DeMaria, Anthony N ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAGAWA UNIVERSITY   (Japan)

^c UCSD MEDICAL CENTER   (United States)

Author keywords

Coronary disease; Echocardiography; Myocardial infarction; Reperfusion

Indexed keywords

CONTRAST MEDIUM; QW 7437; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOG; ENTROPY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HISTOPATHOLOGY; IMAGE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY;

EID: 0035901598     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.15.2021     Document Type: Article

References (20)

1. Lack of myocardial perfusion immediately after successful thrombolysis a predictor of poor recovery of left ventricular function in anterior myocardial infarction
2. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography
3. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction
4. Potential clinical implications of abnormal myocardial perfusion patterns immediately after reperfusion in a canine model: A myocardial contrast echocardiography
5. Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography
6. Myocardial contrast echocardiography versus dobutamine echocardiography for predicting functional recovery after acute myocardial infarction treated with primary coronary angioplasty
7. Combination of dobutamine and myocardial contrast echocardiography to differentiate postischemic from infarcted myocardium
8. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: Identification of myocardial risk area and infarct size in the canine model of ischemia
9. Quantitative texture analysis in two-dimensional echocardiography: Application to the diagnosis of experimental myocardial contusion
10. Quantitative texture analysis in two-dimensional echocardiography: Application to the diagnosis of myocardial amyloidosis
11. Noninvasive diagnosis of cardiac rejection through echocardiographic tissue characterization
12. Safety and efficacy of QW7437, a new fluorocarbon-based echocardiographic contrast agent
13. Early phase myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique
14. Effect of reperfusion on ischemic right ventricular dysfunction disparate mechanism of benefit related to duration of ischemia
15. Local effects of acute cellular injury on regional myocardial flow
16. Progressive impairment of regional myocardial perfusion after initial restoration of post ischemic blood flow
17. Evaluation of dynamic changes in microvascular flow during ischemia-reperfusion by myocardial contrast echocardiography
18. Assessment of regional myocardial blood flow with myocardial contrast two-dimensional echocardiography
19. Flow dynamics of QW7437, a new dodecafluoropentane ultrasound contrast agent, in the microcirculation: Microvascular mechanisms for persistent tissue echo enhancement
20. Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes